146 related articles for article (PubMed ID: 12196184)
1. Toxicity of myoglobin and haemoglobin: oxidative stress in patients with rhabdomyolysis and subarachnoid haemorrhage.
Reeder BJ; Sharpe MA; Kay AD; Kerr M; Moore K; Wilson MT
Biochem Soc Trans; 2002 Aug; 30(4):745-8. PubMed ID: 12196184
[TBL] [Abstract][Full Text] [Related]
2. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure.
Moore KP; Holt SG; Patel RP; Svistunenko DA; Zackert W; Goodier D; Reeder BJ; Clozel M; Anand R; Cooper CE; Morrow JD; Wilson MT; Darley-Usmar V; Roberts LJ
J Biol Chem; 1998 Nov; 273(48):31731-7. PubMed ID: 9822635
[TBL] [Abstract][Full Text] [Related]
3. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure.
Boutaud O; Moore KP; Reeder BJ; Harry D; Howie AJ; Wang S; Carney CK; Masterson TS; Amin T; Wright DW; Wilson MT; Oates JA; Roberts LJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2699-704. PubMed ID: 20133658
[TBL] [Abstract][Full Text] [Related]
4. Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria.
Plotnikov EY; Chupyrkina AA; Pevzner IB; Isaev NK; Zorov DB
Biochim Biophys Acta; 2009 Aug; 1792(8):796-803. PubMed ID: 19545623
[TBL] [Abstract][Full Text] [Related]
5. Hemoglobin and myoglobin associated oxidative stress: from molecular mechanisms to disease States.
Reeder BJ; Wilson MT
Curr Med Chem; 2005; 12(23):2741-51. PubMed ID: 16305469
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure.
Boutaud O; Roberts LJ
Free Radic Biol Med; 2011 Sep; 51(5):1062-7. PubMed ID: 21034813
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of renal failure in rhabdomyolysis: the role of myoglobin.
Holt S; Moore K
Exp Nephrol; 2000; 8(2):72-6. PubMed ID: 10729745
[TBL] [Abstract][Full Text] [Related]
8. Histidine and not tyrosine is required for the peroxide-induced formation of haem to protein cross-linked myoglobin.
Reeder BJ; Cutruzzolà F; Bigotti MG; Watmough NJ; Wilson MT
IUBMB Life; 2007; 59(8-9):477-89. PubMed ID: 17701542
[TBL] [Abstract][Full Text] [Related]
9. Molecular Mechanisms and Novel Therapeutic Approaches to Rhabdomyolysis-Induced Acute Kidney Injury.
Panizo N; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; Moreno JA
Kidney Blood Press Res; 2015; 40(5):520-32. PubMed ID: 26512883
[TBL] [Abstract][Full Text] [Related]
10. The role of myoglobin degradation in nephrotoxicity after rhabdomyolysis.
Zorova LD; Pevzner IB; Chupyrkina AA; Zorov SD; Silachev DN; Plotnikov EY; Zorov DB
Chem Biol Interact; 2016 Aug; 256():64-70. PubMed ID: 27329933
[TBL] [Abstract][Full Text] [Related]
11. Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches.
Guerrero-Hue M; Rubio-Navarro A; Sevillano Á; Yuste C; Gutiérrez E; Palomino-Antolín A; Román E; Praga M; Egido J; Moreno JA
Nefrologia (Engl Ed); 2018; 38(1):13-26. PubMed ID: 28668175
[TBL] [Abstract][Full Text] [Related]
12. Ferryl haem protonation gates peroxidatic reactivity in globins.
Silaghi-Dumitrescu R; Reeder BJ; Nicholls P; Cooper CE; Wilson MT
Biochem J; 2007 May; 403(3):391-5. PubMed ID: 17214588
[TBL] [Abstract][Full Text] [Related]
13. The radical and redox chemistry of myoglobin and hemoglobin: from in vitro studies to human pathology.
Reeder BJ; Svistunenko DA; Cooper CE; Wilson MT
Antioxid Redox Signal; 2004 Dec; 6(6):954-66. PubMed ID: 15548893
[TBL] [Abstract][Full Text] [Related]
14. Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage.
Pyne-Geithman GJ; Morgan CJ; Wagner K; Dulaney EM; Carrozzella J; Kanter DS; Zuccarello M; Clark JF
J Cereb Blood Flow Metab; 2005 Aug; 25(8):1070-7. PubMed ID: 15789034
[TBL] [Abstract][Full Text] [Related]
15. Desferrioxamine inhibits production of cytotoxic heme to protein cross-linked myoglobin: a mechanism to protect against oxidative stress without iron chelation.
Reeder BJ; Wilson MT
Chem Res Toxicol; 2005 Jun; 18(6):1004-11. PubMed ID: 15962935
[TBL] [Abstract][Full Text] [Related]
16. The peroxidatic activities of Myoglobin and Hemoglobin, their pathological consequences and possible medical interventions.
Wilson MT; Reeder BJ
Mol Aspects Med; 2022 Apr; 84():101045. PubMed ID: 34654576
[TBL] [Abstract][Full Text] [Related]
17. Exercise, free radicals and oxidative stress.
Cooper CE; Vollaard NB; Choueiri T; Wilson MT
Biochem Soc Trans; 2002 Apr; 30(2):280-5. PubMed ID: 12023865
[TBL] [Abstract][Full Text] [Related]
18. Oxidative degradation of bilirubin produces vasoactive compounds.
Kranc KR; Pyne GJ; Tao L; Claridge TD; Harris DA; Cadoux-Hudson TA; Turnbull JJ; Schofield CJ; Clark JF
Eur J Biochem; 2000 Dec; 267(24):7094-101. PubMed ID: 11106420
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and mechanism of formation of peroxide-induced heme to protein cross-linking in myoglobin.
Reeder BJ; Svistunenko DA; Sharpe MA; Wilson MT
Biochemistry; 2002 Jan; 41(1):367-75. PubMed ID: 11772036
[TBL] [Abstract][Full Text] [Related]
20. Myoglobin facilitates angiotensin II-induced constriction of renal afferent arterioles.
Liu ZZ; Mathia S; Pahlitzsch T; Wennysia IC; Persson PB; Lai EY; Högner A; Xu MZ; Schubert R; Rosenberger C; Patzak A
Am J Physiol Renal Physiol; 2017 May; 312(5):F908-F916. PubMed ID: 28052871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]